FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/04/052151 [Registered on: 28/04/2023] Trial Registered Prospectively
Last Modified On: 28/04/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   "To evaluate the efficacy of Madhuyashti Granules and Shirodhara in the management of Attention Deficit Hyperactivity Disorder (ADHD) in school going children." 
Scientific Title of Study   "A clinical study to evaluate the efficacy of Madhuyashti Granules and Shirodhara in the management of Attention Deficit Hyperactivity Disorder (ADHD) in school going children." 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Minakshi 
Designation  Reader, Department of Kaumarbhritya 
Affiliation  RGGPG Ayurvedic College and Hospital 
Address  Room no-218, Anatomy Block, RGGPG Ayurvedic College and Hospital, Paprola, Kangra, Himachal Pradesh.
Room no-218, Anatomy Block, RGGPG Ayurvedic College and Hospital, Paprola, Kangra, Himachal Pradesh.
Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418017565  
Fax    
Email  drminakshi2050@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Minakshi 
Designation  Reader, Department of Kaumarbhritya 
Affiliation  RGGPG Ayurvedic College and Hospital 
Address  Room no-218, Anatomy Block, RGGPG Ayurvedic College and Hospital, Paprola, Kangra, Himachal Pradesh.
RGGPG Ayurvedic College and Hospital, Paprola, Kangra, Himachal Pradesh.
Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418017565  
Fax    
Email  drminakshi2050@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Zenia Dharani 
Designation  PG Scholar, Department of Kaumarbhritya 
Affiliation  RGGPG Ayurvedic College and Hospital 
Address  RGGPG Ayurvedic College and Hospital, Paprola, Kangra, Himachal Pradesh.
RGGPG Ayurvedic College and Hospital, Paprola, Kangra, Himachal Pradesh.
Kangra
HIMACHAL PRADESH
176115
India 
Phone  6238516037  
Fax    
Email  zeniadharani7@gmail.com  
 
Source of Monetary or Material Support  
Charak Govt. Ayurvedic Pharmacy Paprola, Distt. Kangra, Herbal garden and Herbarium, Research Institute in ISM, Jogindernagar, Distt. Mandi 
 
Primary Sponsor  
Name  RGGPG Ayurvedic College 
Address  RGGPG Ayurvedic College and Hospital, Paprola, Kangra 176115 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Minakshi  RGGPG Ayurvedic College, Paprola  Room no-218, Anatomy Block, RGGPG Ayurvedic College and Hospital, Paprola, Kangra, Himachal Pradesh.
Kangra
HIMACHAL PRADESH 
9418017565

drminakshi2050@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee (Human)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F909||Attention-deficit hyperactivity disorder, unspecified type. Ayurveda Condition: UNMADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Madhuyashti Granules, Reference: Charaka samhita, Chikitsa sthana, 1/3/30-31, Route: Oral, Dosage Form: Khanda /Granules, Dose: 80(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Milk), Additional Information: -
2Intervention ArmProcedure-takradhArA (Procedure Reference: , Procedure details: Shirodhara is a method of pouring cow’s milk or oil over forehead of patients in the form of a regular stream from a specific height of about 3.14 inches as mentioned in Ayurveda classics in fixed oscillatory movement for 45 minutes per day for two weeks)
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  15.00 Year(s)
Gender  Both 
Details  1. Individual between age group of 6 to 15 years of
both genders having fulfilled DSM V criteria.
2. Children with IQ > 80.
3. Parents of patient willing to participate in the
trial.
 
 
ExclusionCriteria 
Details  1. Individuals below 6 years & above 15 years of
age.
2. Mental disorders like conduct disorder,
anxiety, depressive disorders, obsessive
disorders & compulsive disorder.
3. Children with schizophrenia.
4. Children having medical illness like hearing
loss, hypothyroidism, genetic disorder &
seizures.
5. Children having congenital deformity or
Muscular dystrophy. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Fulfillment of objective criteria.  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
To find out the prevalence of ADHD.  45 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   01/05/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   I would like to publish my research trial after completion as soon as possible. A total of 40 subjects will be studied in two groups. 20 patients will be given Madhuyashti granules and rest 20 will be given both Madhuyashti granules as well as Shirodhara. The outcome will be analyzed with appropriate statistical tools. 
Close